Christopher L Bowlus (Christopher Bowlus)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Topics

Ulcerative Colitis

Atopic Dermatitis

Top Venues

Hepatology communications

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

Abdominal radiology (New York)

This page only lists publications with an associated author ORCID identifier.

Publications

Douglas Thorburn, Diana J Leeming, William T Barchuk, Ya Wang, Xiaomin Lu, Vladislav A Malkov, Kaori L Ito, Christopher L Bowlus, Cynthia Levy, Zachary Goodman, Morten A Karsdal, Andrew J Muir, Jun Xu
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis. Hepatology communications 8 (7) (2024)
Douglas Thorburn, Diana J Leeming, William T Barchuk, Ya Wang, Xiaomin Lu, Vladislav A Malkov, Kaori L Ito, Christopher L Bowlus, Cynthia Levy, Zachary Goodman, Morten A Karsdal, Andrew J Muir, Jun Xu
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis. Hepatology communications 8 (7) (2024)
Douglas Thorburn, Diana J Leeming, William T Barchuk, Ya Wang, Xiaomin Lu, Vladislav A Malkov, Kaori L Ito, Christopher L Bowlus, Cynthia Levy, Zachary Goodman, Morten A Karsdal, Andrew J Muir, Jun Xu
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis. Hepatology communications 8 (7) (2024)
Michael Li, Ruth-Anne Langan Pai, Rachel Gomel, Mary Vyas, Sarah Curup Callif, Joanne Hatchett, Christopher L Bowlus, Jennifer C Lai
Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials. Hepatology communications 8 (6) (2024)
Kris V Kowdley, Gideon M Hirschfield, Charles Coombs, Elizabeth S Malecha, Leona Bessonova, Jing Li, Nuvan Rathnayaka, George Mells, David E Jones, Palak J Trivedi, Bettina E Hansen, Rachel Smith, James Wason, Shaun Kuan Wei Hiu, Dorcas N Kareithi, Andrew L Mason, Christopher L Bowlus, Kate Muller, Marco Carbone, Marina C Berenguer, Piotr Milkiewicz, Femi Adekunle, Alejandra Villamil
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls. The American journal of gastroenterology (2024)
Michael Li, Ruth-Anne Langan Pai, Rachel Gomel, Mary Vyas, Sarah Curup Callif, Joanne Hatchett, Christopher L Bowlus, Jennifer C Lai
Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials. Hepatology communications 8 (6) (2024)
Michael Li, Ruth-Anne Langan Pai, Rachel Gomel, Mary Vyas, Sarah Curup Callif, Joanne Hatchett, Christopher L Bowlus, Jennifer C Lai
Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials. Hepatology communications 8 (6) (2024)
Michael Li, Ruth-Anne Langan Pai, Rachel Gomel, Mary Vyas, Sarah Curup Callif, Joanne Hatchett, Christopher L Bowlus, Jennifer C Lai
Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials. Hepatology communications 8 (6) (2024)
Michael Li, Ruth-Anne Langan Pai, Rachel Gomel, Mary Vyas, Sarah Curup Callif, Joanne Hatchett, Christopher L Bowlus, Jennifer C Lai
Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials. Hepatology communications 8 (6) (2024)
Marlyn J Mayo, John M Vierling, Christopher L Bowlus
Editorial: The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply. Alimentary pharmacology & therapeutics 59 (2) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Erick Cruz Grave, Thomas Loehfelm, Michael T Corwin, Joseph Zepeda, Harjot K Bath, Sandeep Dhaliwal, Maryam Yazdanfar, Christopher L Bowlus
Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis. Abdominal radiology (New York) (2023)
Lisa M Forman, Gonzalo Sapisochin, David N Assis, Lionel Arrivé, Annika Bergquist, Christopher L Bowlus, Mark R Deneau, Sumera Irie Ilyas, Keri E Lunsford, Mercedes Martinez, Rachna T Shroff, James H Tabibian
Reply: Living donor liver transplantation for people with PSC. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Marlyn J Mayo, John M Vierling, Christopher L Bowlus
Editorial: The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply. Alimentary pharmacology & therapeutics 59 (2) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)
Christopher L Bowlus, Bertus Eksteen, Angela C Cheung, Douglas Thorburn, Cynthia A Moylan, Paul J Pockros, Lisa M Forman, Alejandro Dorenbaum, Gideon M Hirschfield, Ciara Kennedy, Thomas Jaecklin, Andrew McKibben, Elaine Chien, Marshall Baek, Pamela Vig, Cynthia Levy
Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatology communications 7 (6) (2023)
Lisa M Forman, Gonzalo Sapisochin, David N Assis, Lionel Arrivé, Annika Bergquist, Christopher L Bowlus, Mark R Deneau, Sumera Irie Ilyas, Keri E Lunsford, Mercedes Martinez, Rachna T Shroff, James H Tabibian
Reply. Hepatology (Baltimore, Md.) (2023)
Marlyn J Mayo, John M Vierling, Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield, Guy W Neff, Michael R Galambos, Stuart C Gordon, Brian B Borg, Stephen A Harrison, Paul J Thuluvath, Aparna Goel, Mitchell L Shiffman, Mark G Swain, David E J Jones, Palak J Trivedi, Andreas E Kremer, Richard J Aspinall, David A Sheridan, Yvonne Dörffel, Ke Yang, Yun-Jung Choi, Charles A McWherter
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis. Alimentary pharmacology & therapeutics (2023)
Christopher L Bowlus, Lionel Arrivé, Annika Bergquist, Mark R Deneau, Lisa Forman, Sumera Irie Ilyas, Keri E Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H Tabibian, David N Assis
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology (Baltimore, Md.) (2022)
Christopher L Bowlus, Cynthia Levy
Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis. Alimentary pharmacology & therapeutics 51 (1) (2020)
Mei Lu, Christopher L Bowlus, Keith Lindor, Carla V Rodriguez-Watson, Robert J Romanelli, Irina V Haller, Heather D Anderson, Jeffrey J VanWormer, Joseph A Boscarino, Mark A Schmidt, Yihe G Daida, Amandeep Sahota, Jennifer Vincent, Jia Li, Sheri Trudeau, Loralee B Rupp, Stuart C Gordon, null null
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis. Clinical epidemiology 12 (2020)
Marlyn J Mayo, Paul J Pockros, David Jones, Christopher L Bowlus, Cynthia Levy, Imran Patanwala, Bruce Bacon, Velimir Luketic, Raj Vuppalanchi, Sharon Medendorp, Alejandro Dorenbaum, Ciara Kennedy, Patricia Novak, Joan Gu, George Apostol, Gideon M Hirschfield
A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. Hepatology communications 3 (3) (2019)
Eric Chak, Amir Taefi, Chin-Shang Li, Moon S Chen, Aaron M Harris, Scott MacDonald, Christopher L Bowlus
Electronic Medical Alerts Increase Screening for Chronic Hepatitis B: A Randomized, Double-Blind, Controlled Trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27 (11) (2018)
Cynthia Levy, Christopher L Bowlus, Elizabeth Carey, Julie M Crawford, Karen Deane, Marlyn J Mayo, W Ray Kim, Michael W Fried
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationale. Hepatology communications 2 (5) (2018)
Zobair M Younossi, Arian Afendy, Maria Stepanova, Andrei Racila, Fatema Nader, Rachel Gomel, Ricky Safer, William R Lenderking, Anne Skalicky, Leah Kleinman, Robert P Myers, G Mani Subramanian, John G McHutchison, Cynthia Levy, Christopher L Bowlus, Kris Kowdley, Andrew J Muir
Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO. Hepatology (Baltimore, Md.) 68 (1) (2018)
Christopher L Bowlus
Scratching the surface of cholestatic itch treatments. Hepatology (Baltimore, Md.) 67 (5) (2018)